Article Details
Retrieved on: 2024-11-12 20:12:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Insilico Medicine has announced positive topline results from its Phase IIa trial of ISM001-055, a novel drug candidate targeting TNIK (Traf2- and ...
Article found on: longevity.technology
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here